Company filings profile · CIK 0000315545
PROVECTUS BIOPHARMACEUTICALS, INC. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT): 16 filings in the last 90 days vs 13 in the prior 90 (filing-velocity rising ↑ · 1.23×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — PROVECTUS BIOPHARMACEUTICALS, INC.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 21, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 2, 2026 | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
Watch PROVECTUS BIOPHARMACEUTICALS, INC. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 5, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 4 | 4 | ↗ |
| May 26, 2026 | 4 | 4 | ↗ |
| May 15, 2026 | 4 | 4 | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 7, 2026 | 4 | 4 | ↗ |
| Apr 30, 2026 | ARS | ARS | ↗ |
| Apr 30, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 30, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 29, 2026 | 4 | 4 | ↗ |
| Apr 21, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Apr 20, 2026 | PRE 14A | PRE 14A | ↗ |
| Apr 6, 2026 | 4 | 4 | ↗ |
| Mar 26, 2026 | 4 | 4 | ↗ |
| Mar 26, 2026 | 10-K | 10-K | ↗ |
| Mar 20, 2026 | 4 | 4 | ↗ |
| Mar 16, 2026 | 4 | 4 | ↗ |
| Mar 6, 2026 | 4 | 4 | ↗ |
| Feb 27, 2026 | 4 | 4 | ↗ |
| Feb 23, 2026 | 4 | 4 | ↗ |
| Feb 23, 2026 | 4 | 4 | ↗ |
| Feb 17, 2026 | 4 | ↗ | |
| Feb 11, 2026 | 4 | 4 | ↗ |
| Feb 9, 2026 | 4 | 4 | ↗ |
| Feb 2, 2026 | 8-K | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Feb 2, 2026 | 4 | 4 | ↗ |
| Jan 29, 2026 | 4 | 4 | ↗ |
| Jan 16, 2026 | 4 | 4 | ↗ |
| Dec 15, 2025 | 4 | ↗ | |
| Dec 8, 2025 | 4 | 4 | ↗ |
| Dec 8, 2025 | SCHEDULE 13D | ↗ | |
| Dec 1, 2025 | SCHEDULE 13D/A | ↗ | |
| Nov 28, 2025 | 4 | ↗ | |
| Nov 21, 2025 | 4 | 4 | ↗ |
| Nov 14, 2025 | 4 | 4 | ↗ |
| Nov 13, 2025 | 10-Q | 10-Q | ↗ |
| Nov 7, 2025 | 4 | 4 | ↗ |
| Oct 31, 2025 | 4 | 4 | ↗ |
| Oct 24, 2025 | 4 | 4 | ↗ |